Диссертация (1174248), страница 19
Текст из файла (страница 19)
– N 66 (4). – P. 411–415.37. Bramham, K. Chronic hypertension and pregnancy outcomes: systematicreview and meta-analysis / K. Bramham, B. Parnell, C. Nelson-Piercy [et al.] // BMJ. –2014 Apr 15. – N 348. – P. g2301.38. Bretelle, F. Maternal endothelial soluble cell adhesion molecules with isolatedsmall for gestational age fetuses: comparison with pre-eclampsia / F.
Bretelle, F.Sabatier, A. Blann [et al.] // BJOG. – 2001. – N 108. – P. 1277–1282.39. Buamah, P. K. Amniotic fluid alkaline ribonuclease activity: an indicator offetal growth retardation and anencephaly / P. K. Buamah, P. H. Scott, A. W. Skillen [etal.] // Clin. Chim. Acta. – 1984. – N 143. – P. 157–162.40. Caramelli, E. Cell-free fetal DNA concentration in plasma of patients withabnormal uterine artery Doppler waveform and intrauterine growth restriction – a pilotstudy / E. Caramelli, N. Rizzo, M. Concu [et al.] // Prenat. Diagn. – 2003. – N 23. – P.367–371.41.
Cartwright, J. E. Remodelling at the maternal-fetal interface: relevance tohuman pregnancy disorders / J. E. Cartwright, R. Fraser, K. Leslie [et al.] //Reproduction. – 2010. – N 140 (6). – P. 803–813.42. Carty, D. M. Novel markers predicting preeclampsia / D. M. Carty, C. Delles,A. F. Dominiczak // Trends Cardiovasc. Med.
– 2008. – N 18 (5). – P. 186–194.43. Carvajal, D. Sensitivity, Specificity, Predictive Values, and Likelihood Ratios/ D. Carvajal, P. Rowe // Pediatr. Rev. – 2010. – N 31 (12). – P. 511–513.44. Chan, K. C. Hypermethylated RASSF1A in maternal plasma: a universal fetalDNA marker that improves the reliability of noninvasive prenatal diagnosis / K. C.Chan // Clin. Chem.
– 2006. – N 52. – P. 2211–2218.45. Cherepanova, A. V. Blood deoxyribonuclease activity in health and diseases /A. V. Cherepanova, S. N. Tamkovich, V. V. Vlasov [et al.] // Biomed. Khim. – 2007. –Vol. 53, N 5. – P. 488–496.10746. Cho, G. Prior cesarean section is associated with increased preeclampsia riskin a subsequent pregnancy / G. Cho, L.
Kim, K. Min [et al.] // BMC PregnancyChildbirth. – 2015. – N 15. – P. 24.47. Christians, J. K. ADAM12 and PAPP-A: candidate regulators of trophoblastinvasion and first trimester markers of healthy trophoblasts / J. K. Christians, A. G.Beristain // Cell Adh. Migr. – 2016. – N 10 (1-2). – P. 147–153.48. Cnossen, J. S. Use of uterine artery Doppler ultrasonography to predict preeclampsia and intrauterine growth restriction: a systematic review and bivariable metaanalysis / J. S. Cnossen, R. K.
Morris, G. ter Riet [et al.] // Can. Med. Assoc. J. – 2008.– N 178 (6). – P. 701–711.49. Combs, C. A. Early-pregnancy proteinuria in diabetes related to preeclampsia/ C. A. Combs, B. Rosenn, J. L. Kitzmiller [et al.] // Obstet. Gynecol. – 1993 Nov. – N82 (5).
– P. 802–807.50. Conde-Agudelo, A. Maternal infection and risk of preeclampsia: systematicreview and metaanalysis / A. Conde-Agudelo, J Villar, M. Lindheimer // Am J. Obstet.Gynecol. – 2008. – N 198 (1). – P. 7–22.51. Conde-Agudelo, A. World Health Organization systematic review ofscreening tests for preeclampsia / A. Conde-Agudelo, J Villar, M. Lindheimer // ObstetGynecol 2004. – N 104 (6). – P. 1367–1391.52. Douglas, K.
A. Eclampsia in the United Kingdom / K. A. Douglas, C. W.Redman // BMJ. – 1994. – N 309. – P. 1395–1400.53. Duke, R. C. IL-2 addition: withdrawal of growth factor activates a suicideprogram in dependent T cells / R. C. Duke, J. J. Cohen // Lymphokine Res. – 1986. – N5. – P. 289–299.54. Endeshaw, M. Diet and Pre-eclampsia: A Prospective Multicentre CaseControl Study in Ethiopia / M. Endeshaw, F. Abebe, M. Bedimo [et al.] // Midwifery. –2015. – N 31(6).
– P. 617–624.55. England, L. Smoking and risk of preeclampsia: a systematic review / L.England, J. Zhang // Front Biosci. – 2007. – N 12. – P. 2471–2483.10856. England, L. J. Effects of maternal smokeless tobacco use on selectedpregnancy outcomes in Alaska Native women: a case-control study / L.
J. England,S. Y. Kim, C. K. Shapiro-Mendoza [et al.] // Acta Obstet. Gynecol. Scand. – 2013. – N92 (6). – P. 648–655.57. Farina, A. Evaluation of cell-free fetal DNA as a second-trimester maternalserum marker of Down syndrome pregnancy / A. Farina, E. S.
Le Shane, G. M.Lambert-Messerlian [et al.] // Clin. Chem. – 2003. – N 49. – P. 239–242.58. Farina, A. Total cell-free DNA (beta-globin gene) distribution in maternalplasma at the second trimester: a new prospective for preeclampsia screening / A.Farina, A. Sekizawa, M. Iwasaki [et al.] // Prenat. Diagn. – 2004. – N 24. – P. 722–726.59. Feig, D. S. Trends in deliveries, prenatal care, and obstetrical complicationsin women with pregestational diabetes: a population-based study in Ontario, Canada,1996–2001 / D.
S. Feig, A. Razzaq, K. Sykora [et al.] // Diabetes Care. – 2006. – N29 (2). – P. 232–235.60. Ferrazzi,E.UterineDopplervelocimetryandplacentalhypoxicischemiclesion in pregnancies with fetal intrauterine growth restriction / E.Ferrazzi, G. Bulfamante, R. Mezzopane [et al.] // Placenta. – 1999. – N 20. – P.
389–394.61. Fleischhacker, M. Circulating nucleic acids (CNAs) and cancer – a survey /M. Fleischhacker // Biochim. Biophys. Acta. – 2007. – Vol. 1775. – P. 181–232.62. Gallo, D. Prediction of Preeclampsia by Mean Arterial Pressure at 11–13 and20–24 Weeks’ Gestation / D. Gallo, L. Poon, M., Fernandez [et al.] // Fetal.
Diagn.Ther. – 2014. – N 36 (1). – P. 28.63. Gillon, T. E. Hypertensive disorders of pregnancy: a systematic review ofinternational clinical practice guidelines / T. E. Gillon, A. Pels, P. von Dadelszen [et al.]// PLoS One. – 2014. – N 9 (12). – P. e113715.64. Gillon, T. E. Hypertensive disorders of pregnancy: a systematic review ofinternational clinical practice guidelines / T. E. Gillon, A. Pels, P. von Dadelszen [et al.]// PLoS One. – 2014. – N 9 (12). – P. e113715.10965. Goetzinger, K.
R. Efficiency of first-trimester uterine artery Doppler, adisintegrin and metalloprotease 12, pregnancy-associated plasma protein A andmaternal characteristics in the prediction of preeclampsia / K. R. Goetzinger, Y. Zhong,A. G. Cahill [et al.] // J. Ultrasound Med. – 2013. – N 32 (9). – P. 1593–1600.66.
Gonzalez-Gonzalez, C. Application of fetal DNA detection in maternalplasma: a prenatal diagnosis unit experience / C. Gonzalez-Gonzalez, M. Garcia-Hoyos,M. J. Trujillo-Tiebas [et al.] // J. Histochem. Cytochem. – 2005. – N 53. – P. 307–314.67. Goodwin, A. A. Does maternal race orethnicity affect the expression ofsevere preeclampsia? / A. A. Goodwin, B. M. Mercer // Am. J. Obstet. Gynecol.
– 2005.– N 193 (3 Pt 2). – P. 973–978.68. Goswami, D. Excess syncytiotrophoblast microparticle shedding is a featureof early-onsetpre-eclampsia, but not normotensive intrauterine growth restriction / D.Goswami, D. S. Tannetta, L. A. Magee [et al.] // Placenta. – 2006. – N 27. – P.
56–61.69. Grill, S. Potential markers of pre-eclampsia – a review / S. Grill, C.Rusterholz, R. Zanetti-Dallenbach [et al.] // Reprod. Biol. Endocrinol. – 2009. – N 7. –P. 70–84.70. Gupta, A. Occurrence of neutrophil extracellular DNA traps (NETs) in preeclampsia: a link with elevated levels of cell-free DNA? / A. Gupta, P. Hasler, S.Gebhardt [et al.] // Ann. NY. Acad. Sci. – 2006. – N 1075. – P. 118–122.71. Hahn, S. Maternal total cell-free DNA in preeclampsia and fetal growthrestriction: Evidence of differences in maternal response to abnormal implantation / S.Hahn, C. Rusterholz, I. Hösli // Placenta. – 2011. – N 32.
– P. 17–20. – DOI: 10.1016/j.placenta.2010.06.018.72. Hanna, J. Decidual NK cells regulate key developmental processes at thehuman fetal-maternal interface / J. Hanna, D. Goldman-Wohl, Y. Hamani [et al.] // Nat.Med. – 2006. – N 12 (9). – P. 1065–1074.73. Hayes, D. K. Maternal Asthma, Diabetes and High Blood Pressure areAssociated with Low Birth Weight and Increased Hospital Birth and Delivery Charges.– N Hawai’i Hospital Discharge Data 2003–2008 / D.
K. Hayes, D. W. Feigal, R. A.Smith, [et al.] // Hawaii J. Med. Public Health. – 2014. – N 73 (2). – P. 49–57.11074. Hirose, N. Risk of Preeclampsia in Women with CKD, Dialysis or KidneyTransplantation / N. Hirose, A. Ohkuchi, S. Rie Usui // Med. J. Obstet. Gynecol. –2014. – N 2 (2). – P. 1028.75. Ito, K. Human urine DNase I: immunological identity with human pancreaticDNase I, and enzymic and proteochemical properties of the enzyme / K.
Ito, N.Minamiura, T. Yamamoto // J. Biochem. – 1984. – N 95. – P. 1399–1406.76. Johnson, M. R. Does endothelial cell activation occur with intrauterinegrowth restriction? / M. R. Johnson, N. Anim-Nyame, P. Johnson [et al.] // BJOG. –2002. – N 109. – P. 836–839.77. Kasawara, K. Exercise and physical activity in the prevention of preeclampsia: systematic review / K. Kasawara, S. do Nascimento, M. Costa [et al.] // ActaObstet.
Gynecol. Scand. – 2012. – N 91 (10). – P. 1147–1157.78. Kishi, K. Genetic polymorphism of human urine deoxyribonuclease I / K.Kishi, T. Yasuda, S. Awazu [et al.] // Hum. Genet. – 1989. – N 81. – P. 295–297.79. Korzeneva, I. B. Comparative analysis of the formation of γH2AX foci inhuman mesenchymal stem cells exposed to 3H-thymidine, tritium oxide, and X-raysirradiation / I. B. Korzeneva, S. V. Kostuyk, L. S. Ershova // Mutat. Res. – 2015.
– N779. – P. 1–15.80. Kristensen, K. Increased cystatin C expression in the pre-eclamptic placenta /K. Kristensen, I. Larsson, S. R. Hansson // Mol. Hum. Reprod. – 2007. – N 13 (3). –P. 189–195.81. Kuc, S. Maternal Characteristics, Mean Arterial Pressure and Serum Markersin Early Prediction of Preeclampsia / S. Kuc, Maria P. H. Koster, A. Franx [et al.] //PLos One. – 2013. – N 8 (5).
– P. e635468.82. Kurki, T. Depression and anxiety in early pregnancy and risk forpreeclampsia / T. Kurki, V. Hiilesmaa, R. Raitasalo [et al.] // Obstet. Gynecol. – 2000. –N 95 (4). – P. 487–490.83. La Torre, R. Placental enlargement in women with primary maternalcytomegalovirus infection is associated with fetal and neonatal disease / R. La Torre, G.Nigro, M. Mazzocco [et al.] // Clin. Infect.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
